Old National Bancorp Iovance Biotherapeutics, Inc. Transaction History

Old National Bancorp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Feb 17, 2023	BUY	$9.53 - $13.11 $285,633 - $392,932	29,972 New	29,972 $287,000
Q3 2022 Nov 08, 2022	SELL	$9.53 - $13.11 $4,765 - $6,555	-500 Reduced 1.64%	29,972 $287,000
Q2 2022 Jul 25, 2022	BUY	$6.38 - $18.33 $194,411 - $558,551	30,472 New	30,472 $336,000

343

247M

2.51M

3.5M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $559M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Old National Bancorp , based on Form 13F filings with the SEC.

Stay updated on Old National Bancorp with notifications on news.